
Medlive Technology Co., Ltd.
2192.HKHKSEHealthcareMedical - Healthcare Information Services
Latest quote
HK$7.55
−HK$0.18 · -2.33%
2192.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteMedlive Technology Co., Ltd., along with its affiliated entities, manages a digital platform tailored for medical professionals, serving both the Chinese mainland and international markets. Through its comprehensive platform, the company delivers a precision marketing and corporate solution encompassing a wide array of services. These include project oversight, clinical supervision, handling of clinical data, biostatistical analysis, drafting of study protocols, medical supervision, patient enrollment, and system support. Furthermore, it offers digital market intelligence, electronic data collection, real-world evidence generation, and the development of application software. Medlive also provides a medical knowledge solution focused on continuing medical education and tools for clinical decision-making, which involves licensing specialized software to physicians and other registered users, including various healthcare practitioners and pharmaceutical corporations. An intelligent patient management solution is another core offering, delivering chronic disease management services that cover online consultations, prescription fulfillment, and patient care facilitated by an Internet hospital. Additionally, it provides condition-specific patient education, involving the creation of content, development of specialized software, and associated support services. Originally established in 1996 as Kingyee Co., Limited, the enterprise adopted the name Medlive Technology Co., Ltd. in 2021. Its corporate headquarters are located in Beijing, China.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Liping Tian
- Listed since
- Jul 15, 2021
- Employees
- 724
Market position
52-week range
Current HK$7.55
- Open
- HK$7.55
- Previous close
- HK$7.73
- Volume
- 876K
- 0.6× average
- Average volume
- 1.45M
- Average daily volume
- Market cap
- 5.59B HKD
- Beta
- 0.44
- Market reference 1
- 50-day average
- HK$7.4299
- +1.62% above average
- 200-day average
- HK$8.9209
- -15.37% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 3.86B CNY
- P/E (TTM)
- 14.39×
- P/B (TTM)
- 0.98×
- P/S (TTM)
- 7.46×
- EV / EBITDA
- 22.06×
- Earnings yield
- 5.21%
- Free cash flow yield
- 1.90%
- Dividend yield
- 3.85%
Profitability & efficiency
- Gross margin
- 60.02%
- Operating margin
- 14.31%
- Net margin
- 52.07%
- Return on equity
- 6.87%
- Return on assets
- 6.48%
- Return on invested capital
- 1.79%
Financial health
- Debt / equity
- 0×
- Current ratio
- 19.09×
- Altman Z-score
- 14.12
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 642.16M CNY | 558.46M CNY | 412M CNY | 314.05M CNY | 284.44M CNY |
| Cost of goods sold | 256.71M CNY | 231.23M CNY | 160.67M CNY | 101.31M CNY | 83.71M CNY |
| Gross profit | 385.44M CNY | 327.22M CNY | 251.34M CNY | 212.74M CNY | 200.73M CNY |
| Research and development | 76.53M CNY | 64.58M CNY | 59.95M CNY | 46.23M CNY | 25.33M CNY |
| Selling, general, and administrative | 217.04M CNY | 208.99M CNY | 177.26M CNY | 151.34M CNY | 127.67M CNY |
| Operating expenses | 293.57M CNY | 273.58M CNY | 231.51M CNY | 197.57M CNY | 153M CNY |
| Interest income | 177.59M CNY | 204.72M CNY | 183.88M CNY | 66.24M CNY | 7.71M CNY |
| Interest expense | 552K CNY | 786K CNY | 361K CNY | 531K CNY | 535K CNY |
| Depreciation and amortization | 7.63M CNY | 3.91M CNY | 9.37M CNY | 8.99M CNY | 6.15M CNY |
| Operating income | 91.87M CNY | 53.65M CNY | 19.82M CNY | 15.17M CNY | 47.74M CNY |
| Net income | 334.34M CNY | 315.15M CNY | 242.3M CNY | 117.32M CNY | 40.62M CNY |
Company facts updated Aug 25, 2026.
Earnings
- EPS beat rate
- 50%
- 3 beats, 3 misses, 0 met estimates
- Average EPS surprise
- -15.27%
- 6 comparable reports
- Latest EPS result
- 0.27
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.2757
2025 complete year+44.2% since 2023
2026 partial: HK$0.1629
HK$0.1912
2,023
HK$0.2695
2,024
HK$0.2757
2,025
HK$0.1629
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | May 19, 2026 | HK$0.1629Semi-Annual | May 21, 2026 | Jun 12, 2026 |
Dividend | Sep 5, 2025 | HK$0.1277Semi-Annual | Sep 8, 2025 | Sep 25, 2025 |
Dividend | May 12, 2025 | HK$0.148Semi-Annual | May 14, 2025 | Jun 6, 2025 |
Dividend | Oct 22, 2024 | HK$0.132Semi-Annual | Oct 24, 2024 | Nov 18, 2024 |
Dividend | May 28, 2024 | HK$0.1375Semi-Annual | May 29, 2024 | Jun 24, 2024 |
Dividend | Nov 7, 2023 | HK$0.1165Semi-Annual | Nov 8, 2023 | Dec 4, 2023 |
Ex-dividend May 19, 2026
HK$0.1629
Semi-Annual
Record May 21, 2026 · Payment Jun 12, 2026
Ex-dividend Sep 5, 2025
HK$0.1277
Semi-Annual
Record Sep 8, 2025 · Payment Sep 25, 2025
Ex-dividend May 12, 2025
HK$0.148
Semi-Annual
Record May 14, 2025 · Payment Jun 6, 2025
Ex-dividend Oct 22, 2024
HK$0.132
Semi-Annual
Record Oct 24, 2024 · Payment Nov 18, 2024
Ex-dividend May 28, 2024
HK$0.1375
Semi-Annual
Record May 29, 2024 · Payment Jun 24, 2024
Ex-dividend Nov 7, 2023
HK$0.1165
Semi-Annual
Record Nov 8, 2023 · Payment Dec 4, 2023
2192.HK peers
ETFs holding 2192.HK
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS2.62M0.00%646.2B USD0.05%$87.20-0.58%
Vanguard FTSE Emerging Markets ETFVWO2.59M0.00%162.3B USD0.06%$59.97-0.79%
iShares Core MSCI Emerging Markets ETFIEMG2.04M0.00%160B USD0.09%$80.49-1.32%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS713.68K0.00%13.6B USD0.06%$158.95-0.69%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX161.16K0.02%685.65M USD0.65%$71.72-0.60%
State Street SPDR Portfolio MSCI Global Stock Market ETFSPGM152.96K0.01%1.74B USD0.09%$87.46-0.39%
Vanguard Total World Stock ETFVT151.69K0.00%97.9B USD0.06%$160.1-0.42%
Matthews Emerging Markets Sustainable Future Active ETF EMSFEMSF119.46K0.30%45.61M USD0.79%$39.1057-1.08%
Vanguard Total International Stock ETFVXUS- Market value
- 2.62M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.20-0.58%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 2.59M
- Weight
- 0.00%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $59.97-0.79%
iShares Core MSCI Emerging Markets ETFIEMG- Market value
- 2.04M
- Weight
- 0.00%
- AUM
- 160B USD
- Expense ratio
- 0.09%
- Price / 1D
- $80.49-1.32%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- Market value
- 713.68K
- Weight
- 0.00%
- AUM
- 13.6B USD
- Expense ratio
- 0.06%
- Price / 1D
- $158.95-0.69%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX- Market value
- 161.16K
- Weight
- 0.02%
- AUM
- 685.65M USD
- Expense ratio
- 0.65%
- Price / 1D
- $71.72-0.60%
State Street SPDR Portfolio MSCI Global Stock Market ETFSPGM- Market value
- 152.96K
- Weight
- 0.01%
- AUM
- 1.74B USD
- Expense ratio
- 0.09%
- Price / 1D
- $87.46-0.39%
Vanguard Total World Stock ETFVT- Market value
- 151.69K
- Weight
- 0.00%
- AUM
- 97.9B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.1-0.42%
Matthews Emerging Markets Sustainable Future Active ETF EMSFEMSF- Market value
- 119.46K
- Weight
- 0.30%
- AUM
- 45.61M USD
- Expense ratio
- 0.79%
- Price / 1D
- $39.1057-1.08%
Continue in GoAI
Research 2192.HKresearch.disclaimer





